As a Schmidt Science Fellow, Kit will combine “liquid biopsies” – simple blood tests that detect tiny fragments of DNA released by cancer cells – with mathematical models to track changes in the cancer’s DNA over time.
Cancer cells often contain extra copies of DNA, stored in additional chromosomes, which may help them develop resistance to treatment.
By uncovering how these chromosomal changes drive resistance in cancer, Kit hopes to enable doctors to predict treatment failure before tumors regrow and respond to relapse sooner.
Kit will pivot from Mathematical Modelling to Genetics & Genomics